Fund · iShares Future Exponential Technologies ETF · measured from SEC filings
XT holdings
XT reports 214 holdings and behaves like 55.1 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.
Measured concentration
as of 2026-07-31Read this figure with the following in mind
1.8% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 54.3
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 72.28% at a quoted market price (level 1), 27 issuer countries.
What stands out
as of 2026-07-31XT's largest investment is Texas Instruments Inc at 5.04% of net assets. Nvidia Corp and Analog Devices Inc follow; the three together are 13.04%. Ten companies are 33.58% of the fund; the other 204 share the rest. Among the 721 equity funds measured here, XT behaves like 55.1 holdings against a median of 42.4 — close to the median. Across 27 quarterly filings XT has become more concentrated: it behaved like 188.2 at 2019-10-31 and 54.2 at 2026-04-30. Between the 2026-01-31 and 2026-04-30 filings 5 positions were added and 5 dropped; 10.7% of the weight moved. the United States is the largest country at 68.76% of the portfolio, across 27 countries in the filing.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2019
27Between 2019-10-31 and 2026-04-30, XT went from behaving like 188.2 equally weighted positions to 54.2 — 71% fewer, while its top ten went from 8.1% to 34.62% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-04-30 | 222 | 54.2 | 34.62% | 5.05% |
| 2026-01-31 | 222 | 56.1 | 33.53% | 4.13% |
| 2025-10-31 | 270 | 128.8 | 18.85% | 2.66% |
| 2025-07-31 | 199 | 181.5 | 9.11% | 1.22% |
| 2025-04-30 | 203 | 188.1 | 7.71% | 0.9% |
| 2025-01-31 | 202 | 197.2 | 6.57% | 0.85% |
| 2024-10-31 | 193 | 172.7 | 9.58% | 1.42% |
| 2024-07-31 | 187 | 176 | 8.32% | 1.24% |
Earlier filings (19 more, back to 2019-10-31)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-04-30 | 200 | 190.3 | 7.45% | 0.94% |
| 2024-01-31 | 203 | 196.9 | 6.32% | 0.7% |
| 2023-10-31 | 196 | 170.2 | 9.96% | 1.35% |
| 2023-07-31 | 199 | 177.4 | 10.19% | 1.23% |
| 2023-04-30 | 201 | 190 | 7.42% | 1.03% |
| 2023-01-31 | 203 | 196.8 | 6.53% | 0.75% |
| 2022-10-31 | 199 | 169.4 | 10.36% | 1.28% |
| 2022-07-31 | 201 | 175.2 | 8.82% | 1.11% |
| 2022-04-30 | 201 | 182 | 8.57% | 1.06% |
| 2022-01-31 | 203 | 196.5 | 6.36% | 0.7% |
| 2021-10-31 | 195 | 180.1 | 8.7% | 1.26% |
| 2021-07-31 | 196 | 186.7 | 7.67% | 1.26% |
| 2021-04-30 | 199 | 191.5 | 6.95% | 0.75% |
| 2021-01-31 | 199 | 195.3 | 6.47% | 0.74% |
| 2020-10-31 | 200 | 169.2 | 10.93% | 2.44% |
| 2020-07-31 | 201 | 179.3 | 9.5% | 1.82% |
| 2020-04-30 | 204 | 190.2 | 7.58% | 1.17% |
| 2020-01-31 | 202 | 198.5 | 6.17% | 0.9% |
| 2019-10-31 | 203 | 188.2 | 8.1% | 1.05% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
1.8% collateralXT's filing lists 215 positions including 1.8% of net assets in securities-lending cash collateral. Counted as filed the fund reads 54.3 effective holdings with a top ten of 33.54%; on its own investments — the figure above — it reads 55.1 with a top ten of 33.58%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-04-30The 15 largest of 214 positions in XT's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: XT.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | TEXAS INSTRUMENTS INCORPORATED | 5.05% | 5.0% |
| 2 | NVIDIA CORPORATION | 4.01% | 9.1% |
| 3 | ANALOG DEVICES, INC. | 4.00% | 13.1% |
| 4 | MICROSOFT CORPORATION | 3.61% | 16.7% |
| 5 | TESLA, INC. | 3.52% | 20.2% |
| 6 | ELI LILLY AND COMPANY | 3.40% | 23.6% |
| 7 | AMAZON.COM, INC. | 3.18% | 26.8% |
| 8 | ALPHABET INC. | 2.83% | 29.6% |
| 9 | JOHNSON & JOHNSON | 2.66% | 32.3% |
| 10 | Taiwan Semiconductor Manufacturing Company Limited | 2.36% | 34.6% |
| 11 | BROADCOM INC. | 2.23% | 36.8% |
| 12 | Infineon Technologies AG | 1.86% | 38.7% |
| 13 | ABBVIE INC. | 1.79% | 40.5% |
| 14 | META PLATFORMS, INC. | 1.67% | 42.2% |
| 15 | INTUITIVE SURGICAL, INC. | 1.64% | 43.8% |
By country of issuer
as of 2026-04-30Share of XT's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| United States | 65.06% |
| United Kingdom | 4.03% |
| Germany | 3.82% |
| Japan | 3.77% |
| Switzerland | 2.99% |
| Cayman Islands° | 2.87% |
| Taiwan | 2.86% |
| Netherlands° | 2.50% |
Returns the fund reported
2019-08 – 2026-04Monthly total returns from Item B.5 of XT's own filings, 81 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference 0.10 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: XT.json · all funds.
Who borrows XT's shares
2026-07-31The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $62m was out to 7 borrowers. The largest, MORGAN STANLEY & CO LLC, held 64.4% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| MORGAN STANLEY & CO LLC | $40m | 64.4% |
| GOLDMAN SACHS & CO. | $14m | 22.4% |
| BofA Securities, Inc. | $4m | 6.2% |
| BNP PARIBAS SECURITIES CORP | $2m | 3.6% |
| UBS AG | $943,955 | 1.5% |
The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter XT has filed, with each borrower: XT.json · all funds.
Since the previous filing
2026-01-31 → 2026-04-30222 positions became 222: 5 added (1.5% of the fund at the later date), 5 dropped (1.8% at the earlier date). Half the sum of all weight changes, a turnover proxy: 10.7%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of XT compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-01-31 | 2026-04-30 | Largest decreases | 2026-01-31 | 2026-04-30 |
|---|---|---|---|---|---|
| TEXAS INSTRUMENTS INCORPORATED | 4.13% | 5.05% | ELI LILLY AND COMPANY | 4.00% | 3.40% |
| Taiwan Semiconductor Manufacturing Company Limited | 1.65% | 2.36% | NOVO NORDISK A/S | 1.10% | 0.60% |
| ANALOG DEVICES, INC. | 3.30% | 4.00% | XIAOMI CORPORATION | 1.68% | 1.20% |
| Murata Manufacturing Co., Ltd. | 0.79% | 1.31% | S&P GLOBAL INC. | 1.75% | 1.28% |
| Infineon Technologies AG | 1.35% | 1.86% | JOHNSON & JOHNSON | 3.08% | 2.66% |
| SK hynix Inc. | 0.40% | 0.79% | ABBVIE INC. | 2.21% | 1.79% |
New: Roche Holding AG (1.48%), Kongsberg Maritime ASA (0.01%), S P500 EMINI FUT JUN26 (0.01%), MSCI EMGMKT JUN26 (0.00%), EURO STOXX 50 JUN26 (0.00%). Gone: Roche Holding AG (1.68%), EXACT SCIENCES CORPORATION (0.10%), MSCI EMGMKT MAR26 (0.00%), S P500 EMINI FUT MAR26 (0.00%), EURO STOXX 50 MAR26 (0.00%).
Asset categories and pricing
as of 2026-07-31| Asset category (as filed) | Share of investments |
|---|---|
| equity EC | 97.95% |
| short-term investment STIV | 1.92% |
| unknown unknown | 0.14% |
72.3% of XT is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Derivative exposure and counterparties
as of 2026-04-30A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $3.86B. Notional of an interest-rate or currency swap is not equity exposure.
Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of XT (55.1). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| XMHQ Invesco S&P MidCap Quality ETF | 81 | 54.1 | 31.61% | 2026-07-31 |
| IFRA iShares U.S. Infrastructure ETF | 164 | 54.4 | 32.36% | 2026-06-30 |
| CGGE Capital Group Global Equity ETF | 115 | 54.6 | 34.07% | 2026-05-31 |
| XMMO Invesco S&P MidCap Momentum ETF | 76 | 54.8 | 28.92% | 2026-07-31 |
| IYY iShares Dow Jones U.S. ETF | 967 | 54.8 | 35.04% | 2026-07-31 |
| CVLC Calvert US Large-Cap Core Responsible Index ETF | 761 | 55.2 | 35.17% | 2026-06-30 |
| GUSA Goldman Sachs MarketBeta U.S. 1000 Equity ETF | 1,012 | 55.3 | 36.13% | 2026-05-31 |
| LSVD LSV Disciplined Value ETF | 131 | 55.6 | 33.22% | 2026-07-31 |
| INDA iShares MSCI India ETF | 170 | 55.7 | 33.88% | 2026-05-31 |
| QDPL Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | 517 | 55.7 | 34.04% | 2026-07-31 |
Essays that examine XT
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.